GAO report recommends FDA evaluate how it recruits, retains BIMO investigators
Regulatory NewsJeff Craven
Audit/inspectionBiologics/ biosimilars/ vaccinesClinical TrialsPharmaceuticalsUnited StatesRegulatory NewsJeff CravenAudit/inspectionBiologics/ biosimilars/ vaccinesClinical TrialsPharmaceuticalsUnited States